The White House is about to turn to vaccine producers to curb the spread of monkeypox

The Covid-19 pandemic isn’t over but the U.S. is already entering a new vaccine boom. But the delayed vaccine rollout continues to raise questions. CNN reports that the U.S. delayed a large-scale vaccine order out of fear of the shots expiring before being administered. Federal agencies are exploring new ways to provide vaccines more efficiently, but the supply shortage poses challenges. For the U.S. government, the best chance at stopping the spread of the virus is to provide more vaccines. The White House knows it and it will work with vaccine makers to ensure that the rollout is expedited.
$Applied DNA Sciences (APDN.US)$ : The company at the forefront of the monkeypox testing revolution. The little-known stock turned heads this week as it began a truly impressive surge.The testing announcement and subsequent rise of APDN stock are occurring amid growing concern of increasing monkeypox infections.
Therefore, robust testing mechanisms may allow government agencies to better control and manage this latest outbreak.